Axogen Selling General Administrative from 2010 to 2024

AXGN Stock  USD 6.97  0.07  0.99%   
Axogen Selling General Administrative yearly trend continues to be very stable with very little volatility. Selling General Administrative is likely to grow to about 36.7 M this year. During the period from 2010 to 2024, Axogen Selling General Administrative quarterly data regression pattern had sample variance of 179.2 T and median of  14,731,105. View All Fundamentals
 
Selling General Administrative  
First Reported
1989-09-30
Previous Quarter
7.5 M
Current Value
10 M
Quarterly Volatility
2.8 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 8.5 M or Total Revenue of 167 M, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 1.39 or PTB Ratio of 2.91. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.
  
Check out the analysis of Axogen Correlation against competitors.

Latest Axogen's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Axogen Inc over the last few years. It is Axogen's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axogen's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Axogen Selling General Administrative Regression Statistics

Arithmetic Mean18,596,064
Geometric Mean13,170,559
Coefficient Of Variation71.99
Mean Deviation12,184,227
Median14,731,105
Standard Deviation13,388,170
Sample Variance179.2T
Range34.9M
R-Value0.96
Mean Square Error13.4T
R-Squared0.93
Slope2,887,753
Total Sum of Squares2509.4T

Axogen Selling General Administrative History

202436.7 M
202334.9 M
202236.8 M
202132.3 M
202026.4 M
201931.3 M
201823.1 M

About Axogen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Axogen income statement, its balance sheet, and the statement of cash flows. Axogen investors use historical funamental indicators, such as Axogen's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Axogen investors may use each financial statement separately, they are all related. The changes in Axogen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axogen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Axogen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Axogen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative34.9 M36.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Axogen Stock

When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out the analysis of Axogen Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.49)
Revenue Per Share
3.804
Quarterly Revenue Growth
0.129
Return On Assets
(0.06)
Return On Equity
(0.22)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.